References
MedImmune Inc. FDA Approves FluMist™ First Nasal Mist Influenza Vaccine Licensed in the US. Media Release: 17 Jun 2003. Available from URL: http://www.medimmune.com
Nichol KL, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. Journal of the American Medical Association 282: 137–144, 14 Jul 1999
Jackson LA, Holmes SJ, Mendelman PM. Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist™, admin-istered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions. Vaccine 17: 1905–1909, 9 Apr 1999
Piedra PA, Yan L, Kotloff K, et al. Safety of the trivalent, coldadapted influenza vaccine in preschool-aged children. Pediatrics 110: 662–672, Oct 2002
Treanor JJ, Kotloff K, Betts RF, et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine 18: 899–906, 10 Dec 1999
Longini Jr IM, Halloran ME, Nizam A, et al. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. Vaccine 18: 1902–1909, 17 Mar 2000
Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, in-tranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. Journal of Pediatrics 136: 168–175, Feb 2000
Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal in-fluenzavirus vaccine in children. New England Journal of Medicine 338: 1405–1412, 14 May 1998
Belshe RB, Gruber WC, Mendelman PM, et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. Journal of Infectious Diseases 181: 1133–1137, Mar 2000
Zangwill KM, Droge J, Mendelman P, et al. Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children. Pediatric Infectious Disease Journal 20: 740–746, Aug 2001
Rights and permissions
About this article
Cite this article
Influenza Virus Vaccine Live Intranasal — MedImmune Vaccines. Drugs R&D 4, 312–319 (2003). https://doi.org/10.2165/00126839-200304050-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-200304050-00007